| Literature DB >> 32239735 |
Wei Wei1,2, Yamin Zhang1,2, Yinfei Li1,2, Yajin Meng1,2, Mingli Li1,2, Qiang Wang1,2, Wei Deng1,2, Xiaohong Ma1,2, Lena Palaniyappan3,4, Nanyin Zhang5, Tao Li1,2.
Abstract
Myelination is key to effective message passing in the central nervous system and is likely linked to the pathogenesis of schizophrenia (SZ). Emerging evidence indicates that a large portion of intracortical myelin insulates inhibitory interneurons that are highly relevant to pathogenesis of schizophrenia. Here for the first time, we characterized intracortical myelination across the entire cortical surface in first-episode treatment-naïve patients with schizophrenia (FES) using T1w/T2w ratio of structural MRI, FES patients exhibited significantly higher myelin content in the left inferior parietal lobe, supramarginal gyrus, and superior temporal gyrus in the superficial layer, as well as left IPL in the middle layer, but significantly lower myelin content in the left middle insula and posterior cingulate gyrus. Years of education, a proxy for onset of functional decline, significantly altered the relationship between abnormal parietal and posterior cingulate myelination and clinical symptoms, indicating that the pathoplastic role of myelination hinges on the age of onset of functional decline. In addition, higher myelination generally related to better cognitive function in younger subjects but worse cognitive function in older subjects. We conclude that FES is characterized by increased myelination of the superficial layers of the parietal-temporal association cortex, but reduced myelination of the cingulo-insular midcortical layer cortex. Intracortical myelin content affects both cognitive functioning and symptom burden in FES, with the effect conditional upon age and timing of onset of functional decline. These results suggest myelination might be a critical biological target for procognitive interventions in SZ.Entities:
Keywords: T1w/T2w ratio; cognitive development; cortical myelination; insula; schizophrenia
Year: 2020 PMID: 32239735 PMCID: PMC7294057 DOI: 10.1002/hbm.24977
Source DB: PubMed Journal: Hum Brain Mapp ISSN: 1065-9471 Impact factor: 5.038
Demographic, cognitive, and clinical data
| FES patients ( | Health ( | Statistics |
| |
|---|---|---|---|---|
| Gender (M/F) | 52/57 | 66/62 |
| .554 |
| Age (years) | 23.69 ± 6.18 | 24.36 ± 5.18 |
| .364 |
| EDUY (years) | 12.40 ± 2.70 | 15.03 ± 2.66 |
| 1.13E−12 |
| BMI | 21.22 ± 3.27 | 20.93 ± 3.16 |
| .501 |
| IQ | ( | ( | ||
| VIQ | 98.03 ± 14.37 | 114.89 ± 12.89 |
| 6.76E−07 |
| PIQ | 92.75 ± 15.48 | 110.75 ± 13.38 |
| 8.86E−09 |
| Total IQ | 95.39 ± 13.75 | 114.36 ± 12.70 |
| 3.03E−10 |
| GAF ( | 46.95 ± 13.72 | – | – | – |
| PANSS ( | – | – | – | |
| Total | 93.03 ± 20.15 | – | – | – |
| Positive | 14.35 ± 4.12 | – | – | – |
| Negative | 21.55 ± 6.82 | – | – | – |
| Disorganization | 10.40 ± 3.40 | – | – | – |
| Excitement | 10.20 ± 4.95 | – | – | – |
| Depression | 7.26 ± 2.95 | – | – | – |
| P6 | 4.23 ± 1.56 | – | – | – |
Abbreviations: BMI, body mass index; EDUY, education year; FES, first‐episode treatment‐naïve patients with schizophrenia; GAF, Global Assessment Function; IQ, intelligence quotient; PANSS, Positive and Negative Syndrome Scale; PIQ, performance intelligence quotient; Total IQ, Total score of intelligence quotient; VIQ, verbal intelligence quotient.
Figure 1Regional differences in myelin content. IPL, inferior parietal lobe; SMG, supramarginal gyrus; STG, superior temporal gyrus; INS, insula; PCG, posterior cingulate gyrus. No significant result was found in deep cortical layer
Figure 2Effect size map of intergroup difference between FES patients and healthy controls. Cohen's d was calculated as the effect size and differed in different cortical layers. Negative Cohen's d values indicated fewer myelin contents in FES patients. Regions with relative high effect size could be observed in the superior frontal gyrus and ventral medial cortex though those regions did not show significant differences after multiple comparison correction
Regional differences of T1w/T2w ratio value
| Peak T | Peak Cohen's | −log | Number of vertex | MNI coordinate | |||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
|
| |||||||
| Left sSMG | 4.85 | 0.72 | 2.52 | 516 | −61 | −46 | 32 |
| Left sIPL | 4.96 | 0.73 | 1.76 | 232 | −49 | −68 | 35 |
| Left sSTG | 4.37 | 0.65 | 1.60 | 160 | −58 | −6 | −6 |
| Left mIPL | 4.92 | 0.73 | 1.80 | 201 | −50 | −68 | 35 |
|
| |||||||
| Left mINS | −4.06 | −0.6 | 1.40 | 201 | −30 | 17 | −24 |
| Left mPCG | −5.05 | −0.75 | 1.80 | 300 | −5 | 1 | 44 |
Abbreviations: FES: first‐episode treatment‐naïve schizophrenia; FWE: family‐wise error; mINS: middle insula; mIPL: middle inferior parietal lobe; mPCG: middle posterior cingulate gyrus; sIPL: superficial inferior parietal lobe; sSMG: superficial supramarginal gyrus; sSTG: superficial superior temporal gyrus.
Correlations between regional myelination and clinical ratings and IQ
| Left sSMG | Left sIPL | Left sSTG | Left mIPL | Left mINS | Left mPCG | |
|---|---|---|---|---|---|---|
| IQ | ||||||
|
| ||||||
| VIQ | −0.007 (.943) | 0.028 (.769) | 0.038 (.685) | −0.02 (.828) | 0.124 (.186) | −0.069 (.464) |
| PIQ | −0.171 (.067) | −0.206 (.028)* | 0.02 (.829) | −0.268 (.004)* | 0.131 (.164) | 0.084 (.372) |
| Total IQ | −0.091 (.335) | −0.083 (.38) | 0.038 (.69) | −0.146 (.119) | 0.154 (.101) | −0.005 (.961) |
|
| ||||||
| VIQ | −0.116 (.281) | 0.101 (.347) | −0.202 (.058) | 0.074 (.491) | −0.012 (.909) | −0.076 (.48) |
| PIQ | −0.012 (.914) | 0.156 (.146) | −0.201 (.061) | 0.235 (.028)* | −0.188 (.080) | −0.126 (.241) |
| Total IQ | −0.130 (.226) | 0.059 (.585) | −0.225 (.034)* | 0.090 (.401) | −0.129 (.230) | −0.109 (.308) |
|
| ||||||
| GAF | 0.076 (.481) | 0.060 (.572) | −0.117 (.272) | 0.158 (.137) | −0.098 (.356) | −0.241 (.022)* |
| PANSS | ||||||
| Positive | −0.029 (.781) | 0.003 (.973) | −0.079 (.445) | 0.132 (.199) | −0.154 (.133) | 0.039 (.707) |
| Negative | −0.001 (.996) | −0.010 (.926) | −0.011 (.912) | −0.096 (.354) | 0.042 (.683) | 0.128 (.214) |
| Disorganization | −0.011 (.913) | −0.110 (.285) | −0.087 (.397) | −0.145 (.158) | 0.067 (.518) | 0.064 (.535) |
| Excitement | −0.165 (.108) | −0.295 (.004)* | −0.083 (.422) | −0.233 (.022)* | −0.037 (.717) | 0.042 (.683) |
| Depression | −0.056 (.587) | −0.044 (.671) | −0.289 (.004)* | −0.011 (.916) | −0.203 (.047)* | −0.117 (.256) |
| P6 | −0.013 (.897) | 0.066 (.520) | −0.193 (.059) | 0.177 (.084) | −0.224 (.028)* | −0.125 (.226) |
Note: *p < .05, not corrected. Results were represented as the correlation coefficient ρ with p in brackets. No correlation survived multiple‐comparison correction.
Abbreviations: FES: first‐episode treatment‐naïve schizophrenia; GAF: Global Assessment Function; IQ: intelligence quotient; mINS: middle insula; mIPL: middle inferior parietal lobe; mPCG: middle posterior cingulate gyrus; PANSS: Positive and Negative Syndrome Scale; PIQ: performance intelligence quotient; sIPL: superficial inferior parietal lobe; sSMG: superficial supramarginal gyrus; sSTG: superficial superior temporal gyrus; VIQ: verbal intelligence quotient.
Figure 3Altered regional myelination associated with clinical ratings. Conditional effects (θ) of regional myelination on clinical ratings across the entire EDUY range using the Johnson–Neyman procedure. mIPL, middle inferior parietal lobe; mPCG, middle posterior cingulate gyrus; EDUY, years of education. Gray regions indicate the 95% confidence interval. Confidence interval contained zero indicates insignificant conditional effect of regional myelination on clinical ratings at corresponding EDUY
Figure 4Altered regional myelination associated with cognitive function. Conditional effects (θ) of regional myelination on cognitive functions across the entire age or EDUY ranges using the Johnson–Neyman procedure. sSMG, superficial supramarginal gyrus; sSTG, superficial superior temporal gyrus; mINS, middle insula; mPCG, middle posterior cingulate gyrus. Gray regions indicate the 95% confidence interval. Confidence interval contained zero indicates insignificant conditional effect of regional myelination on cognitive functions at corresponding age